Archive: revenue growth

Premium

The Third Time Is Not the Charm for This Startup

By Andy Gordon on May 12, 2022

NowRx will complete its third crowdfunding raise on SeedInvest later this month. We’ve recommended it twice. And it has worked out incredibly well for our members who invested.  But the third time is not the charm. We’re not recommending the company this time around.  So, why not? After all, NowRx continues to impress. It’s meeting its ambitious milestones and expanding…
Early investors have few metrics to go by when evaluating potential startup investments. Here are five metrics, in particular, that investors often misconstrue.

Mailbag: Defining Reasonable Revenue Growth

By Early Investing on October 27, 2019

In this week’s Mailbag, the Early Investing team explains reasonable revenue growth numbers and underperforming IPOs.

Mailbag: How to Tell if Your Startup Is Flourishing

By Early Investing on August 25, 2019

This week, the Early Investing team addresses the first thing it notices about a promising startup and how to tell if a startup investment is flourishing.